Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 3C6H11O7.Cr |
Molecular Weight | 637.4381 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cr+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
InChI
InChIKey=ANPGUZATXCGJJH-OPDGVEILSA-K
InChI=1S/3C6H12O7.Cr/c3*7-1-2(8)3(9)4(10)5(11)6(12)13;/h3*2-5,7-11H,1H2,(H,12,13);/q;;;+3/p-3/t3*2-,3-,4+,5-;/m111./s1
Molecular Formula | C6H11O7 |
Molecular Weight | 195.1473 |
Charge | -1 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | Cr |
Molecular Weight | 51.9961 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0004714 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15924436 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | CHROMIUM Approved UseChromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. Launch Date2005 |
PubMed
Title | Date | PubMed |
---|---|---|
Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. | 1994 Jun |
|
Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity. | 1996 Mar |
|
Activation of MAPKs in human bronchial epithelial cells exposed to metals. | 1998 Sep |
|
Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate. | 1999 Dec |
|
Status of antioxidant defense system in chromium-induced Swiss mice tissues. | 2004 Jul |
|
The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment. | 2017 Sep 21 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:32:30 GMT 2025
by
admin
on
Mon Mar 31 21:32:30 GMT 2025
|
Record UNII |
V236ZVR3RL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
V236ZVR3RL
Created by
admin on Mon Mar 31 21:32:30 GMT 2025 , Edited by admin on Mon Mar 31 21:32:30 GMT 2025
|
PRIMARY | |||
|
1311292
Created by
admin on Mon Mar 31 21:32:30 GMT 2025 , Edited by admin on Mon Mar 31 21:32:30 GMT 2025
|
PRIMARY | RxNorm | ||
|
71587119
Created by
admin on Mon Mar 31 21:32:30 GMT 2025 , Edited by admin on Mon Mar 31 21:32:30 GMT 2025
|
PRIMARY | |||
|
33661-40-4
Created by
admin on Mon Mar 31 21:32:30 GMT 2025 , Edited by admin on Mon Mar 31 21:32:30 GMT 2025
|
PRIMARY | |||
|
V236ZVR3RL
Created by
admin on Mon Mar 31 21:32:30 GMT 2025 , Edited by admin on Mon Mar 31 21:32:30 GMT 2025
|
PRIMARY | |||
|
DB14528
Created by
admin on Mon Mar 31 21:32:30 GMT 2025 , Edited by admin on Mon Mar 31 21:32:30 GMT 2025
|
PRIMARY | |||
|
DTXSID20187342
Created by
admin on Mon Mar 31 21:32:30 GMT 2025 , Edited by admin on Mon Mar 31 21:32:30 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
||
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |